ABCDXXX: The obscenity of postmarketing surveillance for teratogenic effects. (Q50796372)

From Wikidata

Jump to navigation Jump to search

scientific article published on 11 July 2012

Language	Label	Description	Also known as
English	ABCDXXX: The obscenity of postmarketing surveillance for teratogenic effects.	scientific article published on 11 July 2012

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/22786781

0 references

ABCDXXX: The obscenity of postmarketing surveillance for teratogenic effects. (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/22786781

0 references

1

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/22786781

publication date

11 July 2012

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/22786781

Birth Defects Research Part A: Clinical and Molecular Teratology

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/22786781

94

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/22786781

8

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/22786781

670-676

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/22786781

Evolving knowledge of the teratogenicity of medications in human pregnancy.

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23043

21 January 2018

Novel statistical tools for monitoring the safety of marketed drugs

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23043

21 January 2018

Quantitative signal detection using spontaneous ADR reporting

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23043

21 January 2018

Developing the Sentinel System--a national resource for evidence development

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23043

21 January 2018

Better data needed from pregnancy registries

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23043

21 January 2018

Drug effects on the fetus and breast-fed infant

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23043

21 January 2018

Determination of human teratogenicity by the astute clinician method: review of illustrative agents and a proposal of guidelines

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23043

21 January 2018

The role of teratology information services in screening for teratogenic exposures: challenges and opportunities

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23043

21 January 2018

Value of the small cohort study including a physical examination for minor structural defects in identifying new human teratogens

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23043

21 January 2018

Neurocognitive Development of Children Following In-Utero Exposure to Labetalol for Maternal Hypertension: A Cohort Study Using a Prospectively Collected Database

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23043

21 January 2018

Combining electronic healthcare databases in Europe to allow for large-scale drug safety monitoring: the EU-ADR Project.

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23043

21 January 2018

Laboratory models and their role in assessing teratogenesis

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23043

21 January 2018

Prescription drug use in pregnancy: a retrospective, population-based study in British Columbia, Canada (2001-2006).

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23043

21 January 2018

New network created to assess drug safety

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23043

21 January 2018

Medical databases in studies of drug teratogenicity: methodological issues

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23043

21 January 2018

How do we know if an exposure is actually teratogenic in humans?

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23043

21 January 2018

Limb deficiency with or without Möbius sequence in seven Brazilian children associated with misoprostol use in the first trimester of pregnancy

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23043

21 January 2018

Safety of medications prescribed before and during early pregnancy in a cohort of 81,975 mothers from the UK General Practice Research Database

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23043

21 January 2018

Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23043

21 January 2018

Increased frequency of isolated cleft palate in infants exposed to lamotrigine during pregnancy

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23043

21 January 2018

Evaluation of selected characteristics of pregnancy drug registries

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23043

21 January 2018

Topiramate in pregnancy: preliminary experience from the UK Epilepsy and Pregnancy Register

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23043

21 January 2018

The importance of dysmorphology in the identification of new human teratogens

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23043

21 January 2018

Pattern of malformations in the children of women treated with carbamazepine during pregnancy

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23043

21 January 2018

The effects of alcohol on fetal development

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23043

21 January 2018

Developmental toxicity testing for safety assessment: new approaches and technologies

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23043

21 January 2018

FDA turns to electronic "sentinel" to flag prescription drug safety problems

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23043

21 January 2018

Medication use during pregnancy and lactation: an urgent call for public health action

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23043

21 January 2018

Alternative models in developmental toxicology

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23043

21 January 2018

Current and future needs for developmental toxicity testing

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23043

21 January 2018

Fetal alcohol spectrum disorders: a practical clinical approach to diagnosis

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23043

21 January 2018

THALIDOMIDE AND CONGENITAL ABNORMALITIES

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23043

21 January 2018

Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008.

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23043

21 January 2018

Congenital connective-tissue defect probably due to D-penicillamine treatment in pregnancy.

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23043

21 January 2018

Diphenylhydantoin and Selected Congenital Malformations

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23043

21 January 2018

Long-term neurodevelopment of children exposed to maternal nausea and vomiting of pregnancy and diclectin

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23043

21 January 2018

Teratogenic exposures

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23043

21 January 2018

We don't know what we don't study: the case for research on medication effects in pregnancy

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23043

21 January 2018

Maternal valproic acid and congenital neural tube defects

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23043

21 January 2018

A basic study design for expedited safety signal evaluation based on electronic healthcare data

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23043

21 January 2018

Pregnancy outcomes in solid organ transplant recipients with exposure to mycophenolate mofetil or sirolimus.

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23043

21 January 2018

Pregnancy registries: differences, similarities, and possible harmonization

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23043

21 January 2018

Cardiovascular malformations with lithium use during pregnancy

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23043

21 January 2018

Case-control studies for identifying novel teratogens.

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23043

21 January 2018

Use of over-the-counter medications during pregnancy

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23043

21 January 2018

Role of Postmarketing Surveillance in Contemporary Medicine

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23043

21 January 2018

Epilepsy and Pregnancy: A Report from the Oxford Record Linkage Study

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23043

21 January 2018

Congenital malformations associated with the administration of oral anticoagulants during pregnancy

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23043

21 January 2018

Identifiers

10.1002/BDRA.23043

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/22786781

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/22786781

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50796372&oldid=1234081856"